Relationship between immunometabolic status and cognitive performance among major depression disorder patients

Mostra el registre complet Registre parcial de l'ítem

  • dc.contributor.author Sánchez-Carro, Yolanda
  • dc.contributor.author De la Torre-Luque, Alejandro
  • dc.contributor.author Portella, Maria J.
  • dc.contributor.author Leal-Leturia, Itziar
  • dc.contributor.author Salvat-Pujol, Neus
  • dc.contributor.author Massaneda, Clara
  • dc.contributor.author de Arriba-Arnau, Aida
  • dc.contributor.author Urretavizcaya, M.
  • dc.contributor.author Peretó, Mar
  • dc.contributor.author Toll Privat, Alba
  • dc.contributor.author Martínez-Ruiz, Antonio
  • dc.contributor.author Ferreiros-Martinez, Raquel
  • dc.contributor.author Álvarez López, Pilar
  • dc.contributor.author Virginia Soria
  • dc.contributor.author López-García, Pilar
  • dc.date.accessioned 2022-09-23T06:19:07Z
  • dc.date.available 2022-09-23T06:19:07Z
  • dc.date.issued 2022
  • dc.description.abstract Background: alterations in cognitive performance have been described in patients with major depressive disorder (MDD). However, the specific risk factors of these changes are not yet known. This study aimed to explore whether inmunometabolic parameters are related to cognitive performance in MDD in comparison to healthy controls (HC) METHODS: sample consisted of 84 MDD patients and 78 HC. Both groups were compared on the results of cognitive performance measured with the Cambridge Neuropsychological Test Automated Battery (CANTAB), the presence of metabolic syndrome (MetS) and an inflammatory/oxidative index calculated by a principal component analysis of peripheral biomarkers (tumor necrosis factor, C-reactive protein and 4-hydroxynonenal). A multiple linear regression was carried out, to study the relationship between inmunometabolic variables and the global cognitive performance, being the latter the dependent variable. Results: significant differences were obtained in the inflammatory/oxidative index between both groups (F(1157)= 12.93; p < .001), also in cognitive performance (F(1157)= 56.75; p < .001). The inmunometabolic covariate regression model (i.e., condition (HC/MDD), sex, age and medication loading, MetS, inflammatory/oxidative index and the interaction between MetS and inflammatory/oxidative index) was statistically significant (F(7157)= 11.24; p < .01) and explained 31% of variance. The condition, being either MDD or HD, (B=-0.97; p < .001), age (B=-0.28; p < .001) and the interaction between inflammatory/oxidative index and MetS (B=-0.38; p = .02) were factors associated to cognitive performance. Limitations: sample size was relatively small. The cross-sectional design of the study limits the possibilities of analysis. Conclusions: our results provide evidence on the conjoint influence of metabolic and inflammatory dysregulation on cognitive dysfunction in MDD patients. In this way, our study opens a line of research in immunometabolic agents to deal with cognitive decline associated with MDD.
  • dc.format.mimetype application/pdf
  • dc.identifier.citation Sánchez-Carro Y, de la Torre-Luque A, Portella MJ, Leal-Leturia I, Salvat-Pujol N, Massaneda C, et al. Relationship between immunometabolic status and cognitive performance among major depression disorder patients. Psychoneuroendocrinology. 2022 Mar; 137: 105631. DOI: 10.1016/j.psyneuen.2021.105631
  • dc.identifier.doi http://dx.doi.org/10.1016/j.psyneuen.2021.105631
  • dc.identifier.issn 0306-4530
  • dc.identifier.uri http://hdl.handle.net/10230/54163
  • dc.language.iso eng
  • dc.publisher Elsevier
  • dc.rights 0306-4530/© 2021 .Sánchez-Carro Y, de la Torre-Luque A, Portella MJ, Leal-Leturia I, Salvat-Pujol N, Massaneda C. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND licenes http://creativecommons.org/licenses/by-nc-nd/4.0/
  • dc.rights.accessRights info:eu-repo/semantics/openAccess
  • dc.rights.uri http://creativecommons.org/licenses/by-nc-nd/4.0/
  • dc.subject.keyword Cognitive performance
  • dc.subject.keyword Inflammation, Oxidative stress
  • dc.subject.keyword Major depressive disorder
  • dc.subject.keyword Metabolic Syndrome
  • dc.title Relationship between immunometabolic status and cognitive performance among major depression disorder patients
  • dc.type info:eu-repo/semantics/article
  • dc.type.version info:eu-repo/semantics/publishedVersion

Col·leccions

Articles (Hospital del Mar Research Institute)